Medical Equipment

Global Epigenetics Market Valuation and Growth Prospects: $28.68 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the epigenetics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Epigenetics Market Size?

The epigenetics market has experienced rapid expansion in recent years. Its size is expected to grow from $10.65 billion in 2024 to $12.74 billion in 2025, achieving a compound annual growth rate (CAGR) of 19.6%. The historical growth of this market is attributable to increased research funding, a rise in the incidence of chronic diseases, advancements in personalized medicine, significant progress in cancer research, and the presence of an aging population.

The epigenetics market is poised for significant expansion over the next few years. It is projected to reach $28.68 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 22.5%. This growth during the forecast period is fueled by epigenetic drug development, the role of epigenetics in environmental health, its application in precision agriculture, robust regulatory support, and increasing patient awareness and advocacy. Notable trends expected in this period include epitranscriptomics, single-cell epigenomics, epigenetic editing, the discovery of epigenetic biomarkers, advances in aging and longevity research, and studies on microbiome-epigenome interactions.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

What Core Market Drivers Are Expanding The Epigenetics Industry?

An escalating incidence of cancer and various other diseases is a significant factor propelling the growth of the epigenetics market. This rising prevalence of diseases consequently increases the demand for epigenetics. For example, in May 2024, information from the National Cancer Institute (NCI), a US-based Government agency, indicated that in 2022, nearly 20 million new cancer cases were reported, resulting in approximately 9.7 million deaths attributed to the disease. Projections further suggest that by 2040, the annual occurrence of new cancer cases will rise to 29.9 million, with cancer-related deaths reaching 15.3 million. Moreover, according to the Centers for Disease Control and Prevention (CDC), an estimated 659,000 people in the United States die of heart disease annually. The increasing prevalence of cancer and other diseases necessitates thorough testing and understanding of genetic modifications, which will invariably boost the utilization and demand for epigenetics. Thus, the growing prevalence of cancer and other diseases is poised to drive the epigenetics market in the coming years.

What Segment Insights Are Highlighted In The Epigenetics Market Report?

The epigeneticsmarket covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

Which Notable Trends Are Transforming The Epigenetics Market Outlook?

Key companies active in the epigenetics market are prioritizing the development of technologically advanced solutions, such as DNA sequencing methods, with the aim of improving precision medicine and enhancing disease understanding and treatment outcomes. DNA sequencing methods are processes utilized to ascertain the order of nucleotides within a DNA molecule, thereby enabling thorough genetic analysis. This information is indispensable for detecting genetic variations linked to diseases and advancing precision medicine. For instance, in March 2023, Illumina Inc., a US-based biotechnology company, unveiled its Illumina Complete Long Read Technology. This technology supports both long-read and short-read sequencing on a single instrument, considerably increasing versatility in genomic research. By requiring less DNA input and featuring a streamlined workflow, it simplifies the library preparation process, making it suitable even for challenging samples. The technology also achieves high accuracy in variant calling, supplying dependable data crucial for comprehensive genomic analysis.

Which Firms Are Driving Innovation Within The Epigenetics Market?

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

What Regional Trends Are Shaping Growth In The Epigenetics Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Tumor Embolization Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795